IT HAS LONG been suspected that the radio resistance of hypoxic cells may be a limiting factor in the treatment of some human tumours by radiotherapy. However, the possibility that such hypoxic cells may also be a problem in the treatment of cancer by chemotherapy has, until recently, received much less attention. There are good grounds, however, for suspecting that such cells may be more drug-resistant than aerobic cells. Firstly, cells which are potentially clonogenic but rendered temporarily hypoxic may become non-cycling or at least slow down in their progression through the mitotic cycle. Secondly, hypoxic cells tend to be located near necrotic, or poorly-vascularized regions in tumours and may be less accessible to cytotoxic drugs. We are examining the effects of the degree and duration of hypoxia on the response of mammalian cells exposed in vitro to a range of chemotherapeutic drugs. This report is concerned with the response of oxic and hypoxic Chinese hamster cells exposed to the drug Adriamycin under various conditions.
MATERIALS AND METHODS
The maintenance and culture of the Chinese hamster V79-379A cells used in this work have been reported elsewhere (Stratford & Adams, 1977) .
Toxicity experiments were carried out by suspending cells in full growth medium (Eagle's Minimum Essential Medium, MEM, plus 7-5% foetal calf serum, FCS) in spinner flasks fitted with a gas inlet/outlet system and a sidearm through which samples could be withdrawn. Flasks containing about 100 ml of a suspension containing asynchronous logphase cells at a concentration of about 5 x 105 cells/ml were placed in a water bath at 37°C.
Adriamvcin was dissolved in distilled water at a concentration of 200 ,ug/ml and diluted appropriately in MEM + 7-5% FCS. Drug was then added to cell suspensions and samples withdrawn at appropriate intervals after the initial inoculation. Cells were washed free of drug by centrifugation and resuspension, counted, serially diluted, plated in MEM + Exponentially growing aerobic cells 4 were exposed to various concentrations of Adriamycin at 37°C, and the surviving fractions measured ( . 10-2 k \ 1Oj.ig/ml time and the concentration of Adriamycin in the medium. Workers have previously shown that aerobic cells in plateau phase are more resistant to Adriamycin than aerobic cells in exponential phase (Krishan & Frei, 1976; Twentyman, 1976; Martin & McNally, 1979; Sutherland et al., 1979) .
We have carried out some similar experiments in order to make a direct comparison of the sensitiveness of aerobic plateau-phase cells and chronically hypoxic cells. Fig. 5 compares survival data for plateau-phase and exponential-phase cells exposed to Adriamycin at 37TC in air. In this experiment cells were grown to plateau phase (1.5 x 106 cells/ml) and then treated with various concentrations of Adriamycin for 1 h. Firstly, plateau-phase aerobic cells are much more resistant than exponential aerobic cells, confirming the earlier published data. Secondly, the plateau-phase cells are at least as resistant as the chronically hypoxic cells. The relative resistance of plateauphase cells to Adriamycin has been attributed to a less efficient uptake of drug (Sutherland et al., 1979; Harris et al., 1979) . We have carried out drug-uptake experiments with chronically hypoxic cells. Chronically hypoxic, aerobic plateauphase and aerobic exponential-phase cells were exposed to various concentrations of Adriamycin for 1 h. Cells were then centrifuged, washed and the number of Adriamycin equivalents per cell estimated. Fig. 6 shows that drug uptake into plateau-phase cells is much less than into exponential cells, which in turn take up less drug than chronically hypoxic cells. 
DISCUSSION
It is known that exponentially growing cells in a culture which is rendered chronically hypoxic show more resistance than normally proliferating cells to bleomycin (Roizin-Towle & Hall, 1978) , Actinomycin D (Adams et al., 1980) and 5-fluorouracil, cytosine arabinoside and vincristine (Smith et al., 1979) . Sutherland and colleagues (1979) investigated the cytotoxic action of Adriamycin in EMT6 tumour cells growing as spheroids in vitro. They found that Adriamycin was less effective in killing cells in spheroids than monolayer cells, either in exponential or plateau-phase. It was proposed that only the peripheral cells of the spheroid take up cytotoxic concentrations of the drug. In support, it was found that cells from dissociated spheroids take up more drug than those in intact spheroids, suggesting a diffusion gradient for the penetration of Adriamycin into spheroids. Notwithstanding these results, Sutherland and colleagues were able to show that the cells in the central regions of the spheroids were most drug-resistant. They concluded that this resistance was not due to differences in the cell-cycle stage of the inner cells, since it was found that exponential and plateau-phase monolayer cells were about equally sensitive when the surviving fraction was plotted as a function of absorbed drug. Thus, other factors related to the metabolic state of the cells or to the microenvironment were thought to be involved in resistance to Adriamycin (Sutherland et al., 1979) .
The in vitro results in this paper demonstrate that chronically hypoxic cells are resistant to the cytotoxic action of Adriamycin. This is not a consequence of cellular uptake of Adriamycin, since the exponential-phase and chronically hypoxic cells take up similar amounts of the drug. Cells need to be held under hypoxic conditions at 37°C for 6 h or more before resistance to Adriamycin becomes maximal. However, resistance is not observed when cells are held in N2 at 15°C, which makes it likely that hypoxia-induced metabolic processes render cells less susceptible to damage by Adriamycin.
Resistance to the cytotoxic action of Adriamycin is not lost when the chronically hypoxic cells are reoxygenated. Oxygenation for 24 h at 37°C is required for cells to return to their original sensitivity, which is a time similar to that required for these cells to return to a state where exponential growth kinetics are observed (E. Smith, unpublished) . Clearly, the toxicity of Adriamycin does not depend directly on the presence of 02. This is further illustrated by comparison of the sensitivities of acutely hypoxic cells (1 h under N2) and aerobic exponential cells, where exposure to Adriamycin results in similar levels of cell killing.
It is concluded that metabolic changes induced in cells by prolonged hypoxia can alter cellular sensitivity to Adriamycin. The results suggest that hypoxia may play an important role, therefore, in determining the response of some solid tumours to treatment regimes containing Adriamycin. 
